| Literature DB >> 18680155 |
Cindy E Neunert1, Geeta S Paranjape, Scott Cameron, Zora R Rogers.
Abstract
We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18680155 DOI： 10.1002/pbc.21709
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN： 1545-5009 Impact factor: 3.167